US Patent 10781242 Interleukin-2 fusion proteins and uses thereof
Patent 10781242 was granted and assigned to Medicenna Therapeutics Corp. on September, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10781242 Interleukin-2 fusion proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
